Surface Acquisition - Consideration paid (Details) - Surface Oncology, Inc. $ / shares in Units, $ in Thousands |
Sep. 08, 2023
USD ($)
$ / shares
shares
|
|---|---|
| Surface Acquisition | |
| Coherus common stock issued | shares | 11,971,460 |
| Share price (in dollars per share) | $ / shares | $ 4.89 |
| Equity of combined company owned by Surface equity holders | $ 58,540 |
| Contingent CVR liability | 5,290 |
| Equity of combined company owned by Surface former employees (1) | 766 |
| Business Combination, Consideration Transferred, Total | $ 64,596 |
| X | ||||||||||
- Definition Amount of consideration transferred, equity of combined company owned by acquiree equity holders. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, equity of combined company owned by acquiree former employees. No definition available.
|
| X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|